Literature DB >> 17296584

Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma.

Maria T Scupoli, Omar Perbellini, Mauro Krampera, Fabrizio Vinante, Federica Cioffi, Giovanni Pizzolo.   

Abstract

We explored the role of interleukin-7 (IL-7) in the bone marrow (BM) stroma-mediated survival of primary T-cell acute lymphoblastic leukemia (T-ALL) cells and normal thymocytes. We presented evidence that IL-7 has a major role in the enhanced survival mediated by BM stroma both in T-ALL cells and thymocytes.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17296584     DOI： 10.3324/haematol.10356

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  22 in total

1.  Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation.

Authors:  Todd A Triplett; Kim T Cardenas; Jessica N Lancaster; Zicheng Hu; Hilary J Selden; Guadalupe J Jasso; Sadhana Balasubramanyam; Kathy Chan; LiQi Li; Xi Chen; Andrea N Marcogliese; Utpal P Davé; Paul E Love; Lauren I R Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-09       Impact factor: 11.205

2.  Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.

Authors:  Alice Melão; Maureen Spit; Bruno A Cardoso; João T Barata
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

3.  CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress.

Authors:  L M Sarmento; V Póvoa; R Nascimento; G Real; I Antunes; L R Martins; C Moita; P M Alves; M Abecasis; L F Moita; R M E Parkhouse; J P P Meijerink; J T Barata
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

Review 4.  The hematopoietic stem cell niche--home for friend and foe?

Authors:  Daniela S Krause; David T Scadden; Frederic I Preffer
Journal:  Cytometry B Clin Cytom       Date:  2012-12-26       Impact factor: 3.058

Review 5.  Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Authors:  Valerie I Brown; Alix E Seif; Gregor S D Reid; David T Teachey; Stephan A Grupp
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Forced expression of indoleamine-2,3-dioxygenase in human umbilical cord-derived mesenchymal stem cells abolishes their anti-apoptotic effect on leukemia cell lines in vitro.

Authors:  Yin Yuan; Xin Lu; Chang-li Tao; Xuan Chen; Hong-wei Shao; Shu-lin Huang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-16       Impact factor: 2.416

Review 7.  Contribution of bone microenvironment to leukemogenesis and leukemia progression.

Authors:  F Ayala; R Dewar; M Kieran; R Kalluri
Journal:  Leukemia       Date:  2009-09-03       Impact factor: 11.528

8.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  RelB-dependent stromal cells promote T-cell leukemogenesis.

Authors:  Nuno R dos Santos; Maryvonne Williame; Stéphanie Gachet; Françoise Cormier; Anne Janin; Debra Weih; Falk Weih; Jacques Ghysdael
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

Review 10.  Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.

Authors:  Alberto M Martelli; Francesca Chiarini; Camilla Evangelisti; Alessandra Cappellini; Francesca Buontempo; Daniela Bressanin; Milena Fini; James A McCubrey
Journal:  Oncotarget       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.